| Intrathecal baclofen therapy over 10 years. | |
| | |
MedLine Citation:
|
PMID: 15673207 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Intrathecal baclofen (ITB) therapy has evolved into a standard treatment for severe spasticity. After this therapy had been provided for 10 years, a retrospective chart review on 50 patients, representing a total 2,922 patient months of ITB service, was done. These patients suffered severe spasticity from a number of disease processes including multiple sclerosis, cerebral palsy, and brain injury. The average dosage for the total group was 463 micrograms per day (microg/day), and 32% used a simple infusion mode. Pump refills occurred every 3 months for 58% of the group. Three evolving trends in ITB therapy were identified from clinical trial to current management: (a) higher catheter tip placement, (b) use of more complex infusion modes, and (c) a decreased complication rate. |
| | |
Authors:
|
Patrice Korth Rawlins |
Related Documents
:
|
15336867 - Diagnosis and treatment of candida vertebral osteomyelitis: clinical experience with a ... 3826097 - Indwelling urinary catheters in the elderly. relation of "catheter life" to formation o... 1484757 - Atypical thrombotic and septic complications of totally implantable venous access devic... 10947017 - A prospective analysis of the cephalic vein cutdown approach for chronic indwelling cen... 7244907 - Aortic valve replacement in the elderly. 21184987 - Identifying patients at risk for premature discontinuation of thienopyridine after coro... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses Volume: 36 ISSN: 0888-0395 ISO Abbreviation: J Neurosci Nurs Publication Date: 2004 Dec |
Date Detail:
|
Created Date: 2005-01-27 Completed Date: 2005-02-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8603596 Medline TA: J Neurosci Nurs Country: United States |
Other Details:
|
Languages: eng Pagination: 322-7 Citation Subset: IM; N |
Affiliation:
|
Neuroscience Implant Program at Via Christi Regional Medical Center, Wichita, KS, USA. patrice_rawlins@via-christi.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Baclofen / administration & dosage*, adverse effects Brain Injuries / drug therapy Cerebral Palsy / drug therapy Child Child, Preschool Drug Implants Humans Infant Injections, Spinal Middle Aged Multiple Sclerosis / drug therapy Muscle Relaxants, Central / administration & dosage*, adverse effects Muscle Spasticity / drug therapy* Patient Satisfaction Retrospective Studies |
| Chemical | |
Reg. No./Substance:
|
0/Drug Implants; 0/Muscle Relaxants, Central; 1134-47-0/Baclofen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The influence of resources on perceived functional limitations among women with multiple sclerosis.
Next Document: West Nile virus--the eye of the storm: a case study.